CSI Market
Sign In | Register

Novavax inc (NVAX) Annual Balance Sheets

Annual · GAAP · USD millions
Access NVAX quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Novavax inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent240.63
Restricted Cash10.88
Marketable Securities, Current SH494.45
Cash & Short-term Investments734.00
Accounts receivable106.45
Inventories11.55
Disposal Group, Including Discontinued Operation, Assets, Current AS87.51
Prepaid Expense And Other Assets Current26.82
Total Current Assets978.28
Equipment/Property/Plant Net44.80
Goodwill net113.46
Intangible Assets0.00
Other Assets, Noncurrent39.97
Lease Right Of Use Asset22.90
Total Assets1,176.51
Liabilities
Accounts Payable, Current AC24.58
Accrued Liabilities, Current AC107.17
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current280.34
Disposal Group, Including Discontinued Operation, Liabilities, Current LI47.87
Total Current Liabilities459.95
Convertible Notes Payable, Noncurrent LO244.21
Total Long-term Debt244.21
Other liabilities, Noncurrent600.10
Contract With Customer Liability Current140.05
Finance Lease Liability Current2.51
Contract With Customer Liability Noncurrent358.94
Finance Lease Liability Noncurrent2.09
Total Liabilities1,304.27
Stockholders' Equity
Treasury Stock Common Value-103.02
Common Stock Value1.65
Treasury Stock Value0.00
Additional Paid In Capital Common Stock4,539.76
Retained Earnings / Accumulated Deficit-4,568.15
Other Equity2.01
Common Stockholder's Equity-127.75
Total Stockholder's Equity-127.75
Liabilities & Stockholder's Equity1,176.51
4 historic quarters locked

Sign in to unlock the full Novavax inc balance sheet history.

Sign In Create Free Account

About Novavax Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: nvax-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001000694-26-000007

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License